Lancet 362 , 16911698 (2003)
doi: 10.22270/jddt.v13i1.5863 Summary Keywords prospective, single-arm, dapagliflozin, saxagliptin, fixed-dose combination, diabetes mellitus type II, India, safety Citation Wangnoo SK, Bhadada SK, Farishta F, Jayaram Naidu GG, Pattnaik I, Manohar KN, Singh KP, Gupta SK, Bharath HS and Ghosh S (2025) Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus a phase 4 study in India
Antibiotics Our sterile antibiotic preparations are designed to support timely medication access across hospital departments while aligning with antimicrobial stewardship initiatives and standardized treatment protocols
Ayn zamanda antrenman ve daha aktif bir yaam tarz iin s daha fazla enerji salar
Peptides and Medical Weight Loss Welcome to Pathway Wellness, your trusted partner on the journey to achieving your weight loss goals
All pricing below comes from the company's landing page and was accurate at the time of this publication in February 2026
